Literature DB >> 12673178

Increased resting Tl-201 lung-to-heart ratio is associated with invasively determined measures of left ventricular dysfunction, extent of coronary artery disease, and resting myocardial perfusion abnormalities.

Gregory P Sanders1, Duane S Pinto, J Anthony Parker, Polyxeni Koutkia, Franz C Aepfelbacher, Peter G Danias.   

Abstract

BACKGROUND: Stress lung thallium 201 uptake correlates with left ventricular (LV) dysfunction and extent of coronary artery disease (CAD). Although Tl-201 is used less commonly for stress imaging, dual-isotope stress and viability protocols continue to use Tl-201 for rest imaging. We sought to investigate the association between increased resting Tl-201 lung-to-heart ratio (LHR) and hemodynamic indices of LV dysfunction, indices of myocardial perfusion, and extent of CAD. METHODS AND
RESULTS: Over a 1-year period, we identified 192 consecutive patients who underwent dual-isotope stress perfusion imaging and cardiac catheterization within 30 days, without interim events or revascularization. Resting LHR was measured, and its association with invasively measured hemodynamic parameters, extent of CAD, and indices of myocardial perfusion at rest and stress was examined. Increased resting Tl-201 LHR was weakly but significantly associated with lower LV ejection fraction (EF) (r = 0.209, P <.05), higher pulmonary capillary wedge pressure (r = 0.25, P <.005), and LV end-diastolic pressure (r = 0.215, P <.01) but not with pulmonary artery systolic pressure. Increased LHR was also weakly associated with rest perfusion abnormalities including the sum rest score (r = 0.271, P <.001) and number of abnormally perfused segments (r = 0.25, P <.001) bud did not correlate with stress perfusion indices or ischemic burden. The 76 patients (40%) with LHR greater than 0.5 were more likely to have LVEF lower than 40% and 3-vessel/left main CAD.
CONCLUSIONS: Increased rest Tl-201 LHR is weakly associated with higher LV end-diastolic pressure and pulmonary capillary wedge pressure and lower LVEF. LHR is also associated with the extent of previously infarcted myocardium and may indicate the presence of 3-vessel/left main CAD.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12673178     DOI: 10.1067/mnc.2003.399

Source DB:  PubMed          Journal:  J Nucl Cardiol        ISSN: 1071-3581            Impact factor:   5.952


  33 in total

1.  Prevalence and correlates of increased lung/heart ratio of thallium-201 during dipyridamole stress imaging for suspected coronary artery disease.

Authors:  F S Villanueva; S Kaul; W H Smith; D D Watson; S K Varma; G A Beller
Journal:  Am J Cardiol       Date:  1990-12-01       Impact factor: 2.778

2.  Comparison of pulmonary uptake with transient cavity dilation after dipyridamole Tl-201 perfusion imaging.

Authors:  Christopher L Hansen; Puxiao Cen; Benjamin Sanchez; Reginald Robinson
Journal:  J Nucl Cardiol       Date:  2002 Jan-Feb       Impact factor: 5.952

3.  Quantitative aspects of myocardial perfusion imaging.

Authors:  S Kaul; D A Chesler; C A Boucher; R D Okada
Journal:  Semin Nucl Med       Date:  1987-04       Impact factor: 4.446

4.  Clinical correlates of Tc-99m sestamibi lung uptake.

Authors:  J B Choy; W D Leslie
Journal:  J Nucl Cardiol       Date:  2001 Nov-Dec       Impact factor: 5.952

5.  Lung thallium-201 uptake after stress testing in patients with coronary artery disease.

Authors:  F G Kushner; R D Okada; H D Kirshenbaum; C A Boucher; H W Strauss; G M Pohost
Journal:  Circulation       Date:  1981-02       Impact factor: 29.690

6.  Postexercise lung uptake of 99mTc-sestamibi determined by a new automatic technique: validation and application in detection of severe and extensive coronary artery disease and reduced left ventricular function.

Authors:  C Bacher-Stier; T Sharir; P B Kavanagh; H C Lewin; J D Friedman; R Miranda; G Germano; D S Berman
Journal:  J Nucl Med       Date:  2000-07       Impact factor: 10.057

7.  Separate acquisition rest thallium-201/stress technetium-99m sestamibi dual-isotope myocardial perfusion single-photon emission computed tomography: a clinical validation study.

Authors:  D S Berman; H Kiat; J D Friedman; F P Wang; K van Train; L Matzer; J Maddahi; G Germano
Journal:  J Am Coll Cardiol       Date:  1993-11-01       Impact factor: 24.094

8.  Independent and incremental prognostic value of exercise single-photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease.

Authors:  A S Iskandrian; S C Chae; J Heo; C D Stanberry; V Wasserleben; V Cave
Journal:  J Am Coll Cardiol       Date:  1993-09       Impact factor: 24.094

9.  Influence of coronary artery disease on pulmonary uptake of thallium-201.

Authors:  J B Bingham; K A McKusick; H W Strauss; C A Boucher; G M Pohost
Journal:  Am J Cardiol       Date:  1980-11       Impact factor: 2.778

10.  Increased thallium lung uptake after exercise in isolated left anterior descending coronary artery disease.

Authors:  P Liu; M Kiess; R D Okada; H W Strauss; P C Block; G M Pohost; C A Boucher
Journal:  Am J Cardiol       Date:  1985-06-01       Impact factor: 2.778

View more
  3 in total

1.  Myocardial perfusion imaging with adenosine triphosphate predicts the rate of cardiovascular events.

Authors:  Isabel Coma-Canella; Jorge Palazuelos; Nieves Bravo; María José García Velloso
Journal:  J Nucl Cardiol       Date:  2006 May-Jun       Impact factor: 5.952

2.  Increased Tl-201 lung uptake on rest imaging but absent Tc-99m tetrofosmin lung uptake on stress imaging in patients with known chronic obstructive pulmonary disease and coronary artery disease with left ventricular dysfunction.

Authors:  Wei-Jen Shih; Primo Milan; Markus Holzhauer
Journal:  J Nucl Cardiol       Date:  2005 Jan-Feb       Impact factor: 5.952

3.  Quantitative relationship of stress Tc-99m sestamibi lung uptake with resting Tl-201 lung uptake and with indices of left ventricular dysfunction and coronary artery disease.

Authors:  Gaurav M Patel; Thomas H Hauser; J Anthony Parker; Duane S Pinto; Gregory P Sanders; Franz C Aepfelbacher; Polyxeni Koutkia; Peter G Danias
Journal:  J Nucl Cardiol       Date:  2004 Jul-Aug       Impact factor: 5.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.